Lung Cancer
Lung Cancer
Advertisement
Coral Olazagasti, MDASCO 2025 | June 18, 2025
Coral Olazagasti, MD, reflects on ASCO 2025 updates and the importance of bringing this news back to patients in the clinic.
Cheryl Czerlanis, MDASCO 2025 | June 13, 2025
Cheryl Czerlanis, MD, shares insights from her ASCO 2025 presentation on the topic.
Molly Li, MBBSASCO 2025 | June 12, 2025
The study participants include those who have had at least one first-degree relative diagnosed with lung cancer.
Laura LitwinNon-Small Cell Lung Cancer | June 11, 2025
The organization also granted priority review, breakthrough designation, and orphan drug designation to the application.
Matthew Smeltzer, PhDASCO 2025 | June 9, 2025
The study compared results from North America with global results by high-income and low- or middle-income countries.
Cheryl Czerlanis, MDASCO 2025 | June 5, 2025
Cheryl Czerlanis, MD, shares insights from the session on lung cancer screening that she chaired at ASCO 2025.
Shriya GargASCO 2025 | June 3, 2025
Palliative care researchers discuss differences in lung cancer treatment disparities across Hispanic patient subgroups.
Helena Yu, MDASCO 2025 | June 6, 2025
Helena Yu, MD, discusses research updates from REZILIENT1 that were presented at ASCO 2025.
Coral Olazagasti, MDASCO 2025 | June 2, 2025
Coral Olazagasti, MD, and Maria Velez, MD, MS, reflect on the opportunities at the ASCO Annual Meeting.
Coral Olazagasti, MDConference Coverage | June 1, 2025
Coral Olazagasti, MD, shares why the ASCO Annual Meeting is a critical time to bring the field together.
Eric Singhi, MDConference Coverage | June 1, 2025
Dr. Singhi unpacks the thoracic oncology data and highlights coming up at this year's ASCO Annual Meeting.
Mara B. Antonoff, MDLung Cancer | May 21, 2025
Mara Antonoff, MD, explains the nuances of determining if a patient with oligometastatic disease is a candidate for surgery.
Cecilia BrownLung Cancer | May 20, 2025
A study of nearly 10,000 lung cancer cases found that only 41% would have been eligible for screening per USPSTF guidelines.
Cecilia BrownLung Cancer | May 19, 2025
The study is evaluating if hydrogen peroxide in exhaled breath condensate can be used as a biomarker for lung cancer.
Cecilia BrownLung Cancer | May 15, 2025
Ravi Rajaram, MD, MSc, discusses Medicaid expansion, timely access to care, regionalization effects, and remaining questions.
Michael R. Gieske, MDLung Cancer | May 9, 2025
Michael R. Gieske, MD, discusses why Lung Cancer Action Week is a key time to promote screening and shares recent milestones.
Stephen V. Liu, MDLung Cancer | May 9, 2025
Dr. Liu discusses his experience as co-chair of the Texas Lung Cancer Conference and shares key highlights.
Alexander Spira, MD, PhDELCC 2025 | May 8, 2025
Dr. Spira shares key data from cohort C of CHRYSALIS-2 that was presented at the European Lung Cancer Congress 2025.
Lung Cancers Today EditorsLung Cancer | May 8, 2025
The ALA and its LUNG FORCE initiative are lighting up buildings and landmarks across the nation this week to inspire action.
Mara B. Antonoff, MDLung Cancer | May 6, 2025
Mara Antonoff, MD, discusses key advances and addresses common misconceptions about operating in oligometastatic disease.
Advertisement